Fairscale Capital’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$44.3K Hold
166
0.03% 204
2025
Q4
$41.6K Hold
166
0.03% 203
2025
Q3
$47.7K Hold
166
0.03% 196
2025
Q2
$43.2K Hold
166
0.03% 197
2025
Q1
$38.6K Sell
166
-72
-30% -$17.5K 0.03% 170
2024
Q4
$54.6K Hold
238
0.05% 156
2024
Q3
$53.2K Sell
238
-86
-27% -$18.9K 0.05% 157
2024
Q2
$70.1K Buy
+324
New +$65.9K 0.06% 140

Other funds holding LH

Fairscale Capital's LH Position: Q1 2026 in Review

Fairscale Capital held its Labcorp (LH) position steady in Q1 2026 at 166 shares worth $44.3K. The position accounts for 0.03% of the portfolio, ranked #204.

Fairscale Capital first reported a position in LH in Q2 2024 and has held it in 8 quarters since. The position peaked at $70.1K in Q2 2024. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Fairscale Capital held 166 shares of Labcorp worth $44.3K as of Q1 2026.
  • Fairscale Capital left its Labcorp share count unchanged in Q1 2026.
  • Labcorp made up 0.03% of Fairscale Capital's portfolio in Q1 2026, its #204 holding.
  • Fairscale Capital first reported a position in Labcorp in Q2 2024 and has held it in 8 quarters since.
  • Fairscale Capital's Labcorp position peaked at $70.1K in Q2 2024.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Fairscale Capital's 13F filing for Q1 2026, filed 11 May 2026.